Chimeric Antigen Receptor T Cell Therapy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor T Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Universities and Colleges
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Perspective (2017-2028)
2.2 Chimeric Antigen Receptor T Cell Therapy Growth Trends by Region
2.2.1 Chimeric Antigen Receptor T Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Chimeric Antigen Receptor T Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor T Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor T Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor T Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Chimeric Antigen Receptor T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antigen Receptor T Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor T Cell Therapy Revenue in 2021
3.5 Chimeric Antigen Receptor T Cell Therapy Key Players Head office and Area Served
3.6 Key Players Chimeric Antigen Receptor T Cell Therapy Product Solution and Service
3.7 Date of Enter into Chimeric Antigen Receptor T Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chimeric Antigen Receptor T Cell Therapy Market Size (2017-2028)
6.2 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)
6.3 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor T Cell Therapy Market Size (2017-2028)
7.2 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)
7.3 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size (2017-2028)
9.2 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)
9.3 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Introduction
11.1.4 Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Detail
11.2.2 Bellicum Pharmaceuticals Business Overview
11.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Introduction
11.2.4 Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Detail
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Introduction
11.3.4 Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.3.5 Bluebird Bio Recent Development
11.4 Caribou Biosciences
11.4.1 Caribou Biosciences Company Detail
11.4.2 Caribou Biosciences Business Overview
11.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.4.4 Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.4.5 Caribou Biosciences Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Introduction
11.5.4 Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.5.5 Celgene Corporation Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Detail
11.6.2 Cellectis Business Overview
11.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Introduction
11.6.4 Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.6.5 Cellectis Recent Development
11.7 Celyad Oncology
11.7.1 Celyad Oncology Company Detail
11.7.2 Celyad Oncology Business Overview
11.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Introduction
11.7.4 Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.7.5 Celyad Oncology Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.8.5 Gilead Sciences Recent Development
11.9 Intellia Therapeutics
11.9.1 Intellia Therapeutics Company Detail
11.9.2 Intellia Therapeutics Business Overview
11.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.9.4 Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.9.5 Intellia Therapeutics Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Introduction
11.10.4 Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.10.5 Johnson & Johnson Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Detail
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.11.4 Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.11.5 Legend Biotech Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Introduction
11.12.4 Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.12.5 Merck Recent Development
11.13 Noile-Immune Biotech
11.13.1 Noile-Immune Biotech Company Detail
11.13.2 Noile-Immune Biotech Business Overview
11.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.13.4 Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.13.5 Noile-Immune Biotech Recent Development
11.14 Novartis
11.14.1 Novartis Company Detail
11.14.2 Novartis Business Overview
11.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Introduction
11.14.4 Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.14.5 Novartis Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Detail
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Introduction
11.15.4 Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.15.5 Pfizer Recent Development
11.16 Sangamo Therapeutics
11.16.1 Sangamo Therapeutics Company Detail
11.16.2 Sangamo Therapeutics Business Overview
11.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.16.4 Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.16.5 Sangamo Therapeutics Recent Development
11.17 Servier Laboratories
11.17.1 Servier Laboratories Company Detail
11.17.2 Servier Laboratories Business Overview
11.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Introduction
11.17.4 Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
11.17.5 Servier Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2017-2022)
Table 8. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2023-2028)
Table 10. Chimeric Antigen Receptor T Cell Therapy Market Trends
Table 11. Chimeric Antigen Receptor T Cell Therapy Market Drivers
Table 12. Chimeric Antigen Receptor T Cell Therapy Market Challenges
Table 13. Chimeric Antigen Receptor T Cell Therapy Market Restraints
Table 14. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players (2017-2022)
Table 16. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2021)
Table 17. Ranking of Global Top Chimeric Antigen Receptor T Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chimeric Antigen Receptor T Cell Therapy Product Solution and Service
Table 21. Date of Enter into Chimeric Antigen Receptor T Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Amgen Company Detail
Table 42. Amgen Business Overview
Table 43. Amgen Chimeric Antigen Receptor T Cell Therapy Product
Table 44. Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 45. Amgen Recent Development
Table 46. Bellicum Pharmaceuticals Company Detail
Table 47. Bellicum Pharmaceuticals Business Overview
Table 48. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product
Table 49. Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 50. Bellicum Pharmaceuticals Recent Development
Table 51. Bluebird Bio Company Detail
Table 52. Bluebird Bio Business Overview
Table 53. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product
Table 54. Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 55. Bluebird Bio Recent Development
Table 56. Caribou Biosciences Company Detail
Table 57. Caribou Biosciences Business Overview
Table 58. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product
Table 59. Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 60. Caribou Biosciences Recent Development
Table 61. Celgene Corporation Company Detail
Table 62. Celgene Corporation Business Overview
Table 63. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product
Table 64. Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. Celgene Corporation Recent Development
Table 66. Cellectis Company Detail
Table 67. Cellectis Business Overview
Table 68. Cellectis Chimeric Antigen Receptor T Cell Therapy Product
Table 69. Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. Cellectis Recent Development
Table 71. Celyad Oncology Company Detail
Table 72. Celyad Oncology Business Overview
Table 73. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product
Table 74. Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. Celyad Oncology Recent Development
Table 76. Gilead Sciences Company Detail
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product
Table 79. Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. Gilead Sciences Recent Development
Table 81. Intellia Therapeutics Company Detail
Table 82. Intellia Therapeutics Business Overview
Table 83. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product
Table 84. Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. Intellia Therapeutics Recent Development
Table 86. Johnson & Johnson Company Detail
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product
Table 89. Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Legend Biotech Company Detail
Table 92. Legend Biotech Business Overview
Table 93. Legend Biotech Chimeric Antigen Receptor T Cell TherapyProduct
Table 94. Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. Legend Biotech Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Chimeric Antigen Receptor T Cell TherapyProduct
Table 99. Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Noile-Immune Biotech Company Detail
Table 102. Noile-Immune Biotech Business Overview
Table 103. Noile-Immune Biotech Chimeric Antigen Receptor T Cell TherapyProduct
Table 104. Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. Noile-Immune Biotech Recent Development
Table 106. Novartis Company Detail
Table 107. Novartis Business Overview
Table 108. Novartis Chimeric Antigen Receptor T Cell TherapyProduct
Table 109. Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Pfizer Company Detail
Table 112. Pfizer Business Overview
Table 113. Pfizer Chimeric Antigen Receptor T Cell TherapyProduct
Table 114. Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. Sangamo Therapeutics Company Detail
Table 117. Sangamo Therapeutics Business Overview
Table 118. Sangamo Therapeutics Chimeric Antigen Receptor T Cell TherapyProduct
Table 119. Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 120. Sangamo Therapeutics Recent Development
Table 121. Servier Laboratories Company Detail
Table 122. Servier Laboratories Business Overview
Table 123. Servier Laboratories Chimeric Antigen Receptor T Cell TherapyProduct
Table 124. Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022) & (US$ Million)
Table 125. Servier Laboratories Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Universities and Colleges Case Studies
Figure 7. Others Case Studies
Figure 8. Chimeric Antigen Receptor T Cell Therapy Report Years Considered
Figure 9. Global Chimeric Antigen Receptor T Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Chimeric Antigen Receptor T Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players in 2021
Figure 13. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2021
Figure 15. North America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2017-2028)
Figure 17. United States Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2017-2028)
Figure 21. Germany Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2017-2028)
Figure 29. China Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2017-2028)
Figure 37. Mexico Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2017-2028)
Figure 41. Turkey Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Amgen Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 44. Bellicum Pharmaceuticals Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 45. Bluebird Bio Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 46. Caribou Biosciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 47. Celgene Corporation Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 48. Cellectis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 49. Celyad Oncology Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 50. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 51. Intellia Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 52. Johnson & Johnson Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 53. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 55. Noile-Immune Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 58. Sangamo Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 59. Servier Laboratories Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Industry Market Size
